Welcome to CDC stacks | Vaccination errors - 58808 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Vaccination errors
Filetype[PDF-1.67 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Frequency and Cost of Vaccinations Administered Outside Recommended Ages — 2014; Six Immunization Information System Sentinel Sites
    Personal Author:
    Rodgers, Loren; Shaw, Lauren; Strikas, Raymond; Hibbs, Beth; Wolicki, JoEllen; Cardemil, Cristina; Weinbaum, Cindy;
    Published:
    December 14 2017
    Source:
    J Pediatr. 193:164-171
    Description:
    Objective: : To quantify vaccinations outside recommended ages by analyzing immunization information system (IIS) records. : Study Design: : We analyzed de-identified records of doses administered during 2014 to persons age ≤17 years within six IIS...
    File Type:
    Filetype[PDF - 108.69 KB]
  2. National 2009 H1N1 Flu Survey (NHFS) : a user's guide for the public-use data file
    Corporate Author:
    National Center for Immunization and Respiratory Diseases(U.S.). National Center for Health Statistics (U.S.). NORC (Organization).
    Published:
    March 2012
    File Type:
    Filetype[PDF - 1.04 MB]
  3. Rotavirus Vaccine Administration Errors — United States, 2006–2013
    Personal Author:
    Hibbs, Beth F.; Miller, Elaine R.; Shimabukuro, Tom T.;
    Published:
    Jan 31 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(4):81.
    Description:
    Two live rotavirus oral vaccines, RotaTeq (RV5) (Merck & Co., Inc.) and Rotarix (RV1) (GlaxoSmithKline Biologicals), are approved for prevention of rotavirus gastroenteritis and recommended at ages 2, 4 (RV5/RV1), and 6 (RV5) months by the Advisory C...
    File Type:
    Filetype[PDF - 118.30 KB]
  4. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
    Personal Author:
    Hesse, Elisabeth M.; Shimabukuro, Tom T.; Su, John R.; Hibbs, Beth F.; Dooling, Kathleen L.; Goud, Ravi; Lewis, Paige; Ng, Carmen S.; Cano, Maria V.;
    Published:
    February 01 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(4):91-94
    Description:
    Recombinant zoster vaccine (RZV; Shingrix), an adjuvanted glycoprotein vaccine, was licensed by the Food and Drug Administration (FDA) and recommended by the Advisory Committee on Immunization Practices for adults aged ≥50 years in October 2017 (1)...
    File Type:
    Filetype[PDF - 180.36 KB]
  5. Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines
    Personal Author:
    Moro, Pedro L.; Perez-Vilar, Silvia; Lewis, Paige; Bryant-Genevier, Marthe; Kamiya, Hajime; Cano, Maria;
    Published:
    June 04 2018
    Source:
    Pediatrics. 142(1)
    Description:
    Objective: : To assess the safety of currently licensed diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines in the US using data from the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system. ...
    File Type:
    Filetype[PDF - 89.97 KB]